We have recently used a rat orthotopic xenograft bladder cancer model to show that while a blocking VEGF antibody reduced tumour take by 50%, tumour formation was abolished by concomitant administration in the drinking water of the oxidative stress blocker N-acetylcysteine (‘Parvolex’) (Brown et al, 2005). Here, VEGFA is linked to urinary bladder cancer.